Prostate cancer screening reduces advanced disease and prostate cancer death but is controversial due to downstream harms including unnecessary biopsies and overtreatment. In 2012 the United States Preventive Services Task Force (USPSTF) recommended against screening men for prostate cancer, a practice common since the early 1990's. This dramatic policy change was opposed by many physicians and patient groups. Our group reported on the Twitter response within 24 hours of these guidelines, showing a missed opportunity for greater advocacy since the majority of tweets did not express an opinion. This article is protected by copyright. All rights reserved.
BJU international. 2019 Feb 27 [Epub ahead of print]
Yaohan Ke, Jacob Taylor, Lynn Lingshan Gao, Hezhi Wang, Han Zhao, Nataliya Byrne, Vaibhav Modgil, Mohit Butaney, Danil V Makarov, Vinay Prabhu, Stacy Loeb
Center for Data Science, New York University, NY, USA., The Departments of Urology, Manhattan Veterans Affairs, NY, USA., University College London Hospitals NHS Foundation Trust, London, UK., The Royal College of Surgeons, Dublin, Ireland., The Departments of Radiology, Manhattan Veterans Affairs, NY, USA.